Medpace Inc. (MEDP)
NASDAQ: MEDP
· Real-Time Price · USD
304.75
2.50 (0.83%)
At close: May 02, 2025, 3:59 PM
306.00
0.41%
After-hours: May 02, 2025, 04:30 PM EDT
0.83% (1D)
Bid | 300.33 |
Market Cap | 8.76B |
Revenue (ttm) | 2.16B |
Net Income (ttm) | 416.39M |
EPS (ttm) | 13.09 |
PE Ratio (ttm) | 23.28 |
Forward PE | 22.08 |
Analyst | Hold |
Ask | 306.5 |
Volume | 255,372 |
Avg. Volume (20D) | 509,690 |
Open | 308.99 |
Previous Close | 302.25 |
Day's Range | 303.51 - 312.25 |
52-Week Range | 250.05 - 459.77 |
Beta | 1.46 |
About MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Aug 11, 2016
Employees 5,900
Stock Exchange NASDAQ
Ticker Symbol MEDP
Website https://www.medpace.com
Analyst Forecast
According to 10 analyst ratings, the average rating for MEDP stock is "Hold." The 12-month stock price forecast is $333, which is an increase of 9.27% from the latest price.
Stock Forecasts1 week ago
-2.32%
Medpace Holdings shares are trading lower. The com...
Unlock content with
Pro Subscription
1 week ago
-2.46%
Medpace Holdings shares are trading lower. The company reported Q1 financial results.